Example: Heart Attack

Search clinical trials for: Modulation of FiO2

Total 10000 results

NCT04450212

Terminated

Vitamin K Supplementation Study in Healthy Volunteers (Aim 2B)

Vitamin K Status
NCT06046196

Completed

Clinical Trial to Evaluate the Efficacy and Safety of Sarpogrelate SR in Patients With Chronic Artery Occlusive Disease

Arterial Occlusive Diseases | Intermittent Claudication
NCT03170180

Completed

Exploratory Study of Drug Sensitivity Prediction Software (IRCR-DReSS) With Patient-derived Tumor Cells of Metastatic Gastric Cancer

Stomach Neoplasms
NCT03249740

Completed

A Depot Formulation of Sunitinib Malate (GB-102) in Subjects With Neovascular (Wet) Age-related Macular Degeneration

Neovascular Age-Related Macular Degeneration
NCT00892177

Completed

Dasatinib and Bevacizumab in Treating Patients With Recurrent or Progressive High-Grade Glioma or Glioblastoma Multiforme

Glioblastoma Multiforme
NCT00806663

Completed

FOLFIRI and Sunitinib in Metastatic Colorectal Cancer

Metastatic Colorectal Cancer | Liver Metastases
NCT02535351

Terminated

Targeted Therapy With or Without Nephrectomy in Metastatic Renal Cell Carcinoma: Liquid Biopsy for Biomarkers Discovery (TARIBO)

Clear-cell Metastatic Renal Cell Carcinoma
NCT02404519

Unknown

Vitamin K2 Effect on Vascular Stiffening in Subjects With a Poor Vitamin K-status

Vascular Stiffness
NCT03172052

Unknown

Evaluating Different Modalities for Pleural Adhesiolysis at Assuit University Hospital

Pleural Effusion
NCT00425386

Completed

Sunitinib and Erlotinib in Treating Patients With Unresectable or Metastatic Kidney Cancer

Kidney Cancer
NCT02446795

Unknown

Isoquercetin as an Adjunct Therapy in Patients With Kidney Cancer Receiving First-line Sunitinib: a Phase I/II Trial (QUASAR)

Kidney Cancer | Renal Cell Carcinoma
NCT00203424

Completed

Treatment of Prostate Cancer With Adjuvant Bevacizumab Plus Erlotinib

Prostate Cancer
NCT00467025

Completed

AMG 386, 20060159 Phase 2, RCC 1st Line in Combination With Sorafenib

Advanced Renal Cell Carcinoma
NCT00353262

Completed

A Study of Xeloda (Capecitabine) in Combination With Oxaliplatin in Patients With Metastatic Colorectal Cancer.

Colorectal Cancer
NCT02657616

Completed

Stroke Prophylaxis of AF-patients: Real-life Effectiveness and Safety of Novel Anticoagulants Compared to VKA

Atrial Fibrillation | Stroke Prophylaxis
NCT00755157

Withdrawn

Metronomic Docetaxel and Bevacizumab in Patients With Small Cell Lung Cancer

Small Cell Lung Cancer
NCT01102595

Completed

Neo-adjuvant Treatment With Temozolomide and Bevacizumab Previous to Temozolomide Plus Radiation Plus Bevacizumab Therapy in Unresectable Glioblastoma

Glioblastomas
NCT02273609

Completed

INR Control and Atrial Fibrillation in Primary Care in Spain (PAULA) (PAULA)

Atrial Fibrillation and Flutter
NCT00720148

Completed

A Phase I Trial of Bortezomib and Sunitinib

Solid Tumors
NCT00159432

Completed

Study of Oxaliplatin, Capecitabine and Bevacizumab as First Line Treatment for Patients With Advanced Colorectal Cancer

Colorectal Cancer
NCT00107315

Terminated

Bevacizumab and Capecitabine as First-Line Therapy in Treating Older Patients With Metastatic Colorectal Cancer

Colorectal Cancer
NCT02013830

Completed

A Study of Avastin (Bevacizumab) and Xeloda (Capecitabine) in Patients With Advanced or Metastatic Liver Cancer

Liver Cancer
NCT00828802

Completed

Lenalidomide and Decitabine in High Grade Myelodysplastic Syndromes

Myelodysplastic Syndromes
NCT01481870

Unknown

Comparison of Sequential Therapies With Sunitinib and Sorafenib in Advanced Renal Cell Carcinoma (CROSS-J-RCC)

Metastatic Renal Cell Carcinoma
NCT00400569

Completed

Phase II Study of Sunitinib Malate for Metastatic and/or Surgically Unresectable Soft Tissue Sarcoma

Leiomyosarcoma | Fibrosarcoma | Liposarcoma | Malignant Fibrous Histiocytoma
NCT00246571

Completed

Study Of SU011248 Versus Chemotherapy For Patients With Previously Treated Triple Receptor Negative Breast Cancer

Breast Neoplasms
NCT00951574

Completed

Prevention of Venous and Arterial Thromboembolism, in Cancer Patients Undergoing Chemotherapy, With a Low Molecular Weight Heparin (Nadroparin Calcium)

Metastatic Cancer | Advanced Cancer
NCT00676702

Completed

A Study of the Enzyme Activity and Safety of Pancrelipase in Patients With Severe Exocrine Pancreatic Insufficiency (EPI)

Steatorrhea | Pancreatitis | Pancreatitis, Chronic | Exocrine Pancreatic Insufficiency
NCT00660621

Unknown

A Phase II Study Of Gliadel, Concomitant Temozolomide And Radiation, Followed By Dose Dense Therapy With Temozolomide Plus Bevacizumab For Newly Diagnosed Malignant High Grade Glioma (KARE004)

Glioma
NCT00111215

Completed

Treatment and Management of Women With Bleeding Disorders

Blood Coagulation Disorders | Blood Platelet Disorders | Menorrhagia | Hematologic Disease | Von Willebrand Disease
NCT03924440

Completed

Ovulation Double Check (Proov) Verification and Usability Testing

Ovulation Disorder
NCT02715336

Unknown

Efficacy and Safety of Medication Used to Stimulate Ovulation

Pregnancy | Ovarian Stimulation | Miscarriages | IVF Cycle | Egg Retrieval | Ovarian Hyperstimulation
NCT03904368

Unknown

The Value of Myomectomy in Women With Intramural Myoma Before IVF.

IVF | Fibroid Uterus
NCT07128251

Not yet recruiting

A Single-Arm, Multicenter, Exploratory Clinical Study of Transarterial Chemoembolization (TACE) Combined With Iparomlimab and Tuvonralimab Injection and Bevacizumab Injection for the Treatment of Unresectable, Non-Metastatic Hepatocellular Carcinoma (HCC)

Hepatocellular Carcinoma (HCC) | Immunotherapy | PD-1 | TACE | CTLA-4
NCT06958484

Not yet recruiting

Iparomlimab and Tuvonralimab Injection (QL1706) Combined With Bevacizumab for Postoperative Adjuvant Therapy in Hepatocellular Carcinoma (HCC) With High Risk of Recurrence

Adjuvant Treatment | HCC - Hepatocellular Carcinoma
NCT06878196

Not yet recruiting

ctDNA-guided First-line Immuno-de-escalation Therapy for IVB-stage and Recurrent Cervical Cancer

Uterine Cervical Neoplasm
NCT06856187

Recruiting

Second-line Standard Treatment Sequential TAS-102 and Bevacizumab Combined With Local Treatment in Advanced Colorectal Cancer (TASBEL)

Metastatic Colorectal Cancer (CRC)
NCT06423144

Not yet recruiting

PD-1/PD-L1 Inhibitors and Anti-angiogenic Therapy Combined With/Without TACE/HAIC in Patients With BCLC B/C Hepatocellular Carcinoma Beyond Up-to-7

Hepatocellular Carcinoma
NCT06408623

Not yet recruiting

Chidamide Combined With Sintilimab and Bevacizumab for the First-line Treatment of Advanced Liver Cancer

Liver Cancer
NCT06035133

Not yet recruiting

Treatment of Low Locally Advanced Rectal Cancer With Radiotherapy Removal TNT Plus Neoadjuvant Therapy

Rectal Cancer
NCT05640609

Recruiting

Capeox Regimen Combined With Sintilimab and Bevacizumab for Gastric Cancer

Stomach Neoplasm
NCT05569681

Recruiting

Two Different Regimens of Bemiparin as a Thromboprophylaxis in Morbidly Obese Surgical Patients

Morbid Obesity
NCT04781270

Recruiting

mFOLFOXIRI+Bev vs. mFOLFOX6+Bev for RAS Mutant Unresectable Colorectal Liver-limited Metastases

Liver Metastases | Colorectal Carcinoma
NCT04699214

Recruiting

Endostar Combined With AI Regimen Compared With AI in Adjuvant Treatment

Other Disorders of Soft Tissues
NCT07075562

Completed

TACE Plus Bevacizumab for Hepatocellular Carcinoma With Portal Vein Invasion

Hepatocellular Carcinoma (HCC)
NCT04667910

Completed

601 Versus Ranibizumab in Patients With Central Retinal Vein Occlusion (CRVO)

Central Retinal Vein Occlusion
NCT07013812

Completed

Tranexamic Acid to Reduce Blood Loss in Women Having Planned Cesarean Section

Cesarean Section | Blood Loss During Surgery
NCT02397954

Completed

A Study to Establish the Safety and Tolerability of Zimura™ (Anti-C5 Aptamer) in Combination With Anti-VEGF Therapy in Subjects With Idiopathic Polypoidal Choroidal Vasculopathy (IPCV)

Idiopathic Polypoidal Choroidal Vasculopathy
NCT03772613

Completed

The Randomized OPTIMAL-ACT Trial

Coronary Artery Disease | Ischemic Heart Disease | Anticoagulant-induced Bleeding | Coronary Syndrome
NCT05690191

Enrolling by invitation

Chidamide in Patients With Recurrent and Refractory Diffuse Large b

Diffuse Large B-cell Lymphoma

Search clinical trials for: Modulation of FiO2

Sponsors and Collaborators

Medical Conditions

Drug Interventions

Conditions

Rare Diseases

Drug Interventions

Dietary Supplements

Sponsor/Collaborators

Locations